Antonio Jimeno

发表

State of the art of the virtual reality applied to design and manufacturing processes

Antonio Jimeno, Alberto Puerta, 2007 .

Bispecific antibodies for cancer therapy: A review

Antonio Jimeno, A. Jimeno, Anuradha Krishnamurthy, 2017, Pharmacology & therapeutics.

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

Yoshimi Anzai, Thomas Galloway, Sue S Yom, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101.

Dara L Aisner, Antonio Jimeno, P. Stephens, 2015, Cancer discovery.

Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer.

Manuel Hidalgo, Aik Choon Tan, Jordy Coffa, 2008, Cancer research.

Patient-derived tumour xenografts as models for oncology drug development

Aik Choon Tan, Antonio Jimeno, A. Jimeno, 2012, Nature Reviews Clinical Oncology.

A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma

Jing Wang, Jill Gilbert, Nabil F. Saba, 2015, Clinical Cancer Research.

In vitro and In vivo Clinical Pharmacology of Dimethyl Benzoylphenylurea, a Novel Oral Tubulin-Interactive Agent

Manuel Hidalgo, Ming Zhao, Robert W. Robey, 2005, Clinical Cancer Research.

NCCN Guidelines ® Insights Head and Neck Cancers , Version 2 . 2017 Featured Updates to the NCCN Guidelines

Bharat B. Mittal, Jill Gilbert, Loren K. Mell, 2017 .

Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas.

Fang Zhang, Molly Kulesz-Martin, Antonio Jimeno, 2012, Oral oncology.

Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

Clement Adebamowo, Ritika Kundra, Steven J. M. Jones, 2018, Cell reports.

Phase II trial of dose‐dense paclitaxel, cisplatin, 5‐fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck

Antonio Jimeno, A. Jimeno, R. Hitt, 2004, Cancer.

A Multicenter Phase I Trial of PX-866, an Oral Irreversible Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Advanced Solid Tumors

Razelle Kurzrock, David S. Hong, Antonio Jimeno, 2012, Clinical Cancer Research.

Head and Neck Cancers, Version 2.2014

Renato Martins, Bharat B. Mittal, Jill Gilbert, 2014 .

Phase I study of vandetanib with radiation therapy with or without cisplatin in locally advanced head and neck squamous cell carcinoma

Steven J Frank, John V Heymach, Lucien Nedzi, 2016, Head & neck.

Data and text mining Text processing through Web services : calling Whatizit

Dietrich Rebholz-Schuhmann, Sylvain Gaudan, Harald Kirsch, 2008 .

Phase I dose escalation study of the oral multi-CDK inhibitor PHA-848125

Manuel Hidalgo, D. D. Von Hoff, Antonio Jimeno, 2008 .

Assessment of epidermal growth factor receptor (EGFR) signaling in paired colorectal cancer and normal colon tissue samples using computer-aided immunohistochemical analysis

Manuel Hidalgo, Antonio Jimeno, C. Iacobuzio-Donahue, 2005, Cancer biology & therapy.